Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Bennett

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
Annals of Neurology|January 25, 2012
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis opticaLukmanee Tradtrantip, Hua Zhang, Samira Saadoun, et al.
Acta Neuropathologica Communications|March 26, 2017
Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelinationYiting Liu, Katherine S Given, Danielle E Harlow, et al.
Brain Structure & Function|August 13, 2024
Evaluation of registration-based vs. manual segmentation of rhesus macaque brain MRIsJoey A Charbonneau, Brittany Davis, Erika P Raven, et al.
Acta Neuropathologica|October 30, 2015
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explantsKevin Blauth, John Soltys, Adeline Matschulat, et al.
Chemistry & Biology|March 26, 2013
Discovery of peptoid ligands for anti-aquaporin 4 antibodiesBindu L Raveendra, Hao Wu, Roberto Baccala, et al.
The Journal of Biological Chemistry|September 20, 2012
A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica immunoglobulin G binding to aquaporin-4Puay-Wah Phuan, Marc O Anderson, Lukmanee Tradtrantip, et al.
Journal of the Neurological Sciences|March 31, 2004
Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessmentKelvin L Chou, Steven L Galetta, Grant T Liu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 10, 2023
Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System ManifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Multiple Sclerosis and Related Disorders|July 27, 2023
Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 22, 2020
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiologyKazuo Fujihara, Jeffrey L Bennett, Jerome de Seze, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
Annals of Neurology|January 25, 2012
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis opticaLukmanee Tradtrantip, Hua Zhang, Samira Saadoun, et al.
Acta Neuropathologica Communications|March 26, 2017
Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelinationYiting Liu, Katherine S Given, Danielle E Harlow, et al.
Brain Structure & Function|August 13, 2024
Evaluation of registration-based vs. manual segmentation of rhesus macaque brain MRIsJoey A Charbonneau, Brittany Davis, Erika P Raven, et al.
Acta Neuropathologica|October 30, 2015
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explantsKevin Blauth, John Soltys, Adeline Matschulat, et al.
Chemistry & Biology|March 26, 2013
Discovery of peptoid ligands for anti-aquaporin 4 antibodiesBindu L Raveendra, Hao Wu, Roberto Baccala, et al.
The Journal of Biological Chemistry|September 20, 2012
A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica immunoglobulin G binding to aquaporin-4Puay-Wah Phuan, Marc O Anderson, Lukmanee Tradtrantip, et al.
Journal of the Neurological Sciences|March 31, 2004
Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessmentKelvin L Chou, Steven L Galetta, Grant T Liu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 10, 2023
Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System ManifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Multiple Sclerosis and Related Disorders|July 27, 2023
Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 22, 2020
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiologyKazuo Fujihara, Jeffrey L Bennett, Jerome de Seze, et al.
Pageof 20